The report provides a detailed analysis essential for establishing a racecadotril production plant. It encompasses all critical aspects necessary for racecadotril production, including the cost of racecadotril production, racecadotril plant cost, racecadotril production costs, and the overall racecadotril production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a racecadotril production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Racecadotril is an antidiarrhoeal medicine that is mainly used in the healthcare industry for the treatment of acute diarrhoea. It is primarily utilised as an antidiarrhoeal medicine that helps reduce excessive fluid loss from the intestines without affecting normal bowel movement. It works by lowering the secretion of water and electrolytes in the intestine, helping the body regain balance. It finds its main application in hospitals, clinics, and pharmaceutical formulations for both adults and children suffering from diarrhoea caused by infections or other conditions. Moreover, it is often used as an important component in oral medications to manage dehydration risks and improve patient recovery. It also finds its application in combination therapies, where it supports rehydration treatment in gastrointestinal disorders. Additionally, it is also utilised as a component in the production of various medicinal products, including capsules, tablets, and sachets associated with modern digestive healthcare.
The market for racecadotril is predominantly driven by its application as an antidiarrhoeal medicine for the treatment of acute diarrhoea, which boosts its demand in the pharmaceutical industry. Its usage in hospitals and clinics as a supportive treatment for both adults and children significantly drives its demand in the medical and healthcare sectors. Its application as a medication for treatment plans in combination with rehydration solutions to improve patient recovery and comfort further promotes its demand in the medical and pharmaceutical industries. Its demand as a reference drug in research settings to support the development of new digestive-health medicines also contributes to its demand in the medical and pharmaceutical research industries. Improvements in production methods, dependable suppliers, sustainable sourcing practices, and efficient distribution networks also shape its procurement decisions worldwide. Industrial racecadotril procurement also depends on the price and steady supply of main raw materials, adherence to strict regulatory standards, and the need for quality assurance in pharmaceutical production.
Raw Material for Racecadotril Production
According to the racecadotril production plant project report, the major raw materials for racecadotril production include benzaldehyde, diethyl malonate, paraformaldehyde, diethylamine, thioacetic acid, and benzyl glycinate p-toluenesulphonate.
Production Process of Racecadotril
The extensive racecadotril production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of racecadotril begins with the condensation of benzaldehyde and diethyl malonate to form a substituted malonate intermediate, which is then reduced and hydrolysed to obtain benzyl malonic acid. Further, this acid is reacted with paraformaldehyde and diethylamine to generate benzyl acrylic acid through a condensation step. Then, thioacetic acid is introduced to add the required thioester functionality to the molecule. In the final step, this intermediate is condensed with benzyl glycinate p-toluenesulphonate to build the complete structure of racecadotril, after which the product is purified to obtain pure racecadotril.
Racecadotril is an antidiarrhoeal prodrug that acts as a peripheral enkephalinase inhibitor, and it is also commonly known as Acetorphan. It appears as a white to tan crystalline powder that is practically insoluble in water but soluble in dimethyl sulfoxide (DMSO). The molecular formula of the compound is C21H23NO4S, and its molar mass is 385.48 g/mol. Its density is approximately 1.206 g/cm³, and it has a melting point of 88–90 degrees Celsius. Its boiling point is approximately 574.5 degrees Celsius. The compound is classified as harmful if swallowed and is very toxic to aquatic life. It is sold under the trade name Hidrasec. The most common side effects associated with the compound include headache, drowsiness, and nausea, and in rare cases, skin reactions such as rash, urticaria, and angioedema may occur. It is recommended to store the compound in a dry, sealed container at room temperature, away from light, and to handle it with appropriate protective equipment.